The effect of estrogen on the microenvironment of breast cancer is mainly reflected in the CAF-dependent induction of Tamoxifen (TAM) drug resistance, TAM and G1 induced CYP19A1 gene expression and increased E2 production, but also through the GPER/EGFR/ERK pathway [114]. This evidence concerns the gene GPER1 and breast carcinoma.